CCFM
FLNA

Clear Creek Financial Management’s Filana Therapeutics FLNA Stock Holding History

Clear Creek Financial Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,383
Closed -$33.6K – 576
2025
Q1 		$33.6K Sell
22,383
-6,609
-23% -$16.7K ﹤0.01% 517
2024
Q4 		$68.4K Sell
28,992
-124,541
-81% -$2.19M 0.01% 464
2024
Q3 		$4.52M Buy
153,533
+7,983
+5% +$184K 0.51% 40
2024
Q2 		$1.8M Buy
145,550
+7,025
+5% +$148K 0.22% 93
2024
Q1 		$2.81M Buy
138,525
+3,920
+3% +$90.3K 0.36% 60
2023
Q4 		$3.03M Buy
134,605
+30,265
+29% +$639K 0.48% 44
2023
Q3 		$1.74M Buy
104,340
+8,757
+9% +$174K 0.3% 71
2023
Q2 		$2.34M Sell
95,583
-2,409
-2% -$58K 0.41% 58
2023
Q1 		$2.36M Buy
97,992
+30,722
+46% +$851K 0.45% 56
2022
Q4 		$1.99M Buy
67,270
+51,390
+324% +$1.85M 0.44% 56
2022
Q3 		$664K Sell
15,880
-11,100
-41% -$300K 0.15% 121
2022
Q2 		$759K Buy
26,980
+11,150
+70% +$282K 0.16% 120
2022
Q1 		$588K Buy
15,830
+5,050
+47% +$214K 0.09% 168
2021
Q4 		$471K Buy
10,780
+5,675
+111% +$298K 0.07% 190
2021
Q3 		$317K Buy
+5,105
New +$426K 0.05% 233

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Clear Creek Financial Management's FLNA Position: Q2 2025 in Review

Clear Creek Financial Management sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 22,383 shares — an estimated $33.6K sold.

Clear Creek Financial Management first reported a position in FLNA in Q3 2021 and held it in 15 quarters. The position peaked at $4.52M in Q3 2024. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Clear Creek Financial Management reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Clear Creek Financial Management sold 22,383 Filana Therapeutics shares in Q2 2025, an estimated $33.6K.
  • Clear Creek Financial Management first reported a position in Filana Therapeutics in Q3 2021 and held it in 15 quarters.
  • Clear Creek Financial Management's Filana Therapeutics position peaked at $4.52M in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Clear Creek Financial Management's 13F filing for Q2 2025, filed 23 Jul 2025.